The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human gliom

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Wainwright, Derek A ^a   Sengupta, Sadhak ^a   Han, Yu ^a   Ulasov, Ilya V ^a   Lesniak, Maciej S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; BRAIN TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; HELPER CELL; IMMUNOLOGY; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; BRAIN NEOPLASMS; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; INTERLEUKIN-17; MICE; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 78149453343     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015390     Document Type: Article

References (23)

1. DeAngelis LM (2001) Medical progress: brain tumors. N Engl J Med 344: 114-123.
2. El Andaloussi A, Lesniak MS (2006) An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme. Neuro Oncol 8: 234-243.
3. El Andaloussi A, Lesniak MS (2007) CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas. J Neurooncol 83: 145-152.
4. El Andaloussi A, Han Y, Lesniak MS (2006) Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors. J Neurosurg 105: 430-437.
5. Curtin JF, Candolfi M, Fakhouri TM, Liu C, Alden A, et al. (2008) Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials. PLoS One 3: e1983.
6. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, et al. (1995) Human IL-17: a novel cytokine derived from T cells. J Immunol 155: 5483-5486.
7. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
8. Wong CK, Lun SW, Ko FW, Wong PT, Hu SQ, et al. (2009) Activation of peripheral Th17 lymphocytes in patients with asthma. Immunol Invest 38: 652-664.
9. Gocke AR, Cravens PD, Ben LH, Hussain RZ, Northrop SC, et al. (2007) T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J Immunol 178: 1341-1348.
10. Siciliano NA, Skinner JA, Yuk MH (2006) Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response. J Immunol 177: 7131-7138.
11. Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W (2007) Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 178: 6730-6733.
12. Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF, et al. (2010) Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 184: 1630-1641.
13. Gerosa M, Semenzato G, Amadori G, Olivi A, Rotilio A, et al. (1981) Long-term immunological investigation of malignant intracranial gliomas. Surg Neurol 16: 48-52.
14. Wainwright DA, Xin J, Mesnard NA, Politis CM, Sanders VM, et al. (2009) Effects of facial nerve axotomy on Th2- and Th1-associated chemokine expression in the facial motor nucleus of wild-type and presymptomatic mSOD1 mice. J Neuroimmunol 216: 66-75.
15. Wainwright DA, Xin J, Mesnard NA, Beahrs TR, Politis CM, et al. (2009) Exacerbation of facial motoneuron loss after facial nerve axotomy in CCR3- deficient mice. ASN Neuro 1: e00024.
16. Wainwright DA, Xin J, Mesnard NA, Sanders VM, Jones KJ (2010) Toll-like receptor 2 and facial motoneuron survival after facial nerve axotomy. Neurosci Lett 471: 10-14.
17. Sharma MD, Hou DY, Liu Y, Koni PA, Metz R, et al. (2009) Indoleamine 2,3- dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor- draining lymph nodes. Blood 113: 6102-6111.
18. Gounaris E, Blatner NR, Dennis K, Magnusson F, Gurish MF, et al. (2009) T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res 69: 5490-5497.
19. Emamaullee JA, Davis J, Merani S, Toso C, Elliott JF, et al. (2009) Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 58: 1302-1311.
20. Sundrud MS, Koralov SB, Feuerer M, Calado DP, Kozhaya AE, et al. (2009) Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response. Science 324: 1334-1338.
21. Steinman L (2010) Mixed results with modulation of TH-17 cells in human autoimmune diseases. Nat Immunol 11: 41-44.
22. Kostianovsky AM, Maier LM, Anderson RC, Bruce JN, Anderson DE (2008) Astrocytic regulation of human monocytic/microglial activation. J Immunol 181: 5425-5432.
23. Schwartzbaum JA, Huang K, Lawler S, Ding B, Yu J, et al. (2010) Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma. Neuro Oncol 12: 320-327.